This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2020-2026.
Company Filing History:
Years Active: 2020-2026
Title: Hideaki Kageji: Innovator in Cancer Treatment
Introduction: Hideaki Kageji is an esteemed inventor based in Tokyo, Japan, known for his groundbreaking work in the development of a pyridine compound with RET kinase inhibiting action for combating diseases such as cancer.
Latest Patents: Hideaki Kageji holds one patent for the innovative compound represented by the general formula (I), used for its pharmaceutical benefits in cancer treatment.
Career Highlights: Currently affiliated with Daiichi Sankyo Company, Limited, Hideaki Kageji has showcased his expertise in the field of pharmaceuticals and oncology through his pioneering research and patented invention.
Collaborations: Throughout his career, Hideaki Kageji has collaborated closely with fellow researchers and coworkers such as Hiroaki Inagaki and Yoshihiro Shibata, contributing to the collective efforts in advancing medical science and drug development.
Conclusion: Hideaki Kageji's dedication to pushing the boundaries of innovation in cancer therapy highlights his significant contributions to the biomedical field, paving the way for enhanced treatment options and improved patient outcomes.